Brettanomyces anomalus.
A wild yeast found in fermented drinks that may contribute to gut microbial diversity. Produces acetic acid and fermentation metabolites. May contribute to postbiotic compounds in fermented products. No proven health mechanism as a supplement.
Reviewed March 2026
- Category
- Probiotic
- Also filed under
- Microbial diversityFermentation byproducts
What Brettanomyces anomalus is, and what it does.
- Does it work
- Not as a standalone health ingredient. If it happens to be in your kombucha, fine. But nobody should seek this out.
- How much to take
- No established dose. This isn't a therapeutic ingredient.
- Time to feel it
- Nobody has measured a time course for it. It hasn't been studied as something you take and track, only as an organism working inside a fermentation.
- The first dose
- Nothing. Zero. This isn't an active health ingredient.
- With regular use
- No evidence of long-term health benefits from supplementation.
- How well tolerated
- Generally well tolerated in food amounts. It's been in wine and fermented beverages for centuries.
- How it feels
- There's no sensation attached to it. What it changes is the aroma and flavour of a fermented drink, which you taste rather than feel.
- The overlooked benefit
- Its beta-glucosidase enzymes clip sugar groups off bound plant compounds, which is how brewers and winemakers use it to release aroma that was locked up in the fruit.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- No clinical trials as a probiotic
- Known fermentation organism
- May produce postbiotic metabolites in fermented foods
Questions people ask about Brettanomyces anomalus.
- Is this actually a probiotic?
- Not by clinical standards. It's a fermentation yeast that shows up in supplement blends because of its presence in kombucha cultures. No human health trials exist.
- Why is it in my supplement?
- Probably because it's naturally part of a fermented food culture blend. It's not there for therapeutic reasons.
- Is it harmful?
- No. People have consumed it in fermented beverages for centuries. It's safe, just not therapeutic.
- Should I look for supplements with this?
- No need to seek it out. It adds nothing as a health ingredient. If it's in your kombucha-based product, that's fine but incidental.
- How is this different from Saccharomyces boulardii?
- Night and day. S. boulardii has hundreds of clinical trials. Brettanomyces has zero as a probiotic. They're completely different organisms.
- Does it survive stomach acid?
- Unknown. Nobody has studied its survival through the human GI tract because nobody has studied it as a probiotic.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Lactobacillus plantarum produces lactic and acetic acid, and Brettanomyces esterifies those acids into ethyl esters, which is the defining chemistry of mixed culture fermentation. Each organism consumes what the other leaves behind.
Torulaspora delbrueckii shapes the early ester and glycerol profile while Brettanomyces works slowly on the residual sugars later in the same vessel. Their activity windows barely overlap, so they layer instead of competing.
Both are non-Saccharomyces yeasts that tolerate low nutrient and high acid conditions and use different residual carbon sources. They co-occur in aged mixed fermentations without one displacing the other.
Yeast cells lack the bacterial cell wall targets that most antibacterials act on. That is why S. boulardii is the standard example of a yeast used alongside antibacterial therapy. Any yeast in a formula shares that property, which is a pharmacological point about the organism rather than a claim of equivalent evidence: S. boulardii has a human literature and B. anomalus does not.
In mixed fermentations, lactic acid bacteria acidify the medium while Brettanomyces species tolerate low pH and consume residual sugars and dextrins that the bacteria leave behind. The relationship is documented in fermented beverage and food systems. It describes microbial ecology in a vessel, not a demonstrated effect in a person.
Brettanomyces species carry strong beta-glucosidase activity, which cleaves glycosidic bonds. Freed sugars and simplified substrates are then available to saccharolytic bacteria. The cross-feeding logic is sound in fermentation systems and has not been shown for this species in the human gut.
The mechanism is the same glycosidase cross-feed described for other bifidobacteria. Support is by analogy from fermentation ecology rather than from a study on this pairing. Label it early and do not extend it further than that.
Yeasts including Brettanomyces carry invertase activity that splits fructans. That converts a fibre the host cannot digest into substrate the microbial community can. This is fermentation biochemistry and it explains substrate use, not a health outcome.
Shorter chains are cleaved faster than long-chain inulin. In a mixed culture that shifts which organism gets the sugar first. The point is substrate competition and cross-feeding, both measured in vitro.
Brettanomyces has limited galactosidase activity compared with its glucosidase activity, so GOS tends to favour bacterial members of a mixed culture over the yeast. That makes this a competition row rather than an additive one. It is in vitro ecology.
Any yeast preparation, live or inactivated, delivers cell wall beta-glucan and mannan as part of its structure. That is settled cell wall biochemistry across the ascomycete yeasts. It means a Brettanomyces preparation and a purified yeast beta-glucan overlap in what they contribute, which is a compositional statement.
Brettanomyces species are used industrially for their beta-glucosidase, which cleaves the sugar off flavonoid glycosides. The aglycone is absorbed by a different route than the glycoside. This is a well characterised enzyme activity of the organism, demonstrated in fermentation and in vitro systems.
Removing the rutinose sugar is the required step before rutin's flavonoid core can be absorbed to any degree. Yeasts with glucosidase and rhamnosidase activity perform that cleavage. The conversion is documented enzymology. The downstream consequence in a person is not established here.
The organism decarboxylates hydroxycinnamic acids such as p-coumaric and ferulic acid to vinylphenols, then reduces those to ethylphenols. That reaction is the reason it is tracked in winemaking. It changes the phenolic profile of a grape-derived matrix rather than adding an antioxidant effect.
Oregano oil phenols partition into lipid membranes and increase permeability, which is the basis of their antifungal activity in vitro. Taken alongside a live yeast preparation they work against its viability. This is an anti-synergy worth stating plainly in any formula that contains both.
Caprylic acid crosses the fungal membrane in its undissociated form and acidifies the cytoplasm, which is standard medium-chain fatty acid antifungal chemistry. Combining it with a live yeast in the same formula undercuts the yeast. Formulators should separate them.
Talk to a doctor before taking Brettanomyces anomalus if any of these apply to you: No human clinical trials as probiotic, Primarily a fermentation organism. These are flags to check first, not effects Brettanomyces anomalus is known to cause.
Not medical advice. Show the label to your pharmacist.What Brettanomyces anomalus actually does.
Brettanomyces anomalus is an ascomycete yeast, the anamorph of Dekkera anomala. You find it in spontaneous fermentations of beer, wine, cider and sourdough, not in commercial probiotic manufacture.
Like other ascomycete yeasts, its cell wall is beta-1,3 and beta-1,6 glucan with a mannoprotein layer on the outside, plus a chitin fraction at the bud scars.
It carries a lot of beta-glucosidase activity, which snips sugar groups off glycosides. That's the enzymatic reason it gets used in fermentation to release bound aroma compounds.
Brettanomyces species decarboxylate hydroxycinnamic acids into vinylphenols, then reduce those to ethylphenols such as 4-ethylphenol and 4-ethylguaiacol. That reaction is what makes the genus easy to spot in wine.
Where Brettanomyces anomalus comes from.
This is a yeast that turns up naturally in wine, beer and sourdough fermentations rather than being made as a supplement. It is grown on sugar, spun out of the liquid, and kept either alive as a culture or killed by heat so that only the cell walls remain.
Produced by a cultured organism rather than harvested. The strain is selected and the conditions are controlled, so batches sit closer together than a field crop.
The organism grows on fermentable sugars and dextrins, historically arriving on grapes, grain or barrel wood rather than being deliberately added.
Cells consume sugars anaerobically to ethanol and carbon dioxide, and characteristically continue on dextrins and residual sugars after Saccharomyces has stopped.
Biomass is separated from the medium by centrifugation or settling. In practice this species is usually captured from a spontaneous culture rather than propagated from a commercial bank.
Held as a live slurry, or dried and heat-treated to give a non-viable preparation.
There is no established commercial probiotic supply chain for this species, so a strain designation, an origin culture bank and a viable count are usually absent. Without a strain identifier, nothing published about the genus can be tied to a specific product.
Getting Brettanomyces anomalus from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
